Symbol:
Akr1b8
Name:
aldo-keto reductase family 1, member B8
RGD ID:
1550101
MGI Page
MGI
Description:
Predicted to enable several functions, including NADP binding activity; geranylgeranyl reductase activity; and oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor. Predicted to be located in extracellular region and lysosome. Predicted to be active in cytosol and mitochondrion. Is expressed in several structures, including alimentary system; central nervous system; ear; genitourinary system; and respiratory system. Orthologous to several human genes including AKR1B10 (aldo-keto reductase family 1 member B10).
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
aldehyde reductase; aldose reductase-related protein 2; AR; Fg; Fgf; Fgfrp; Fgrp; fibroblast growth factor regulated protein; fibroblast growth factor-regulated protein; FR-1
RGD Orthologs
Alliance Orthologs
No known orthologs.
More Info
homologs ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Other homologs 2
Homo sapiens (human):
AKR1B10 (aldo-keto reductase family 1 member B10)
HGNC
Ensembl, HGNC, HomoloGene, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Homo sapiens (human):
AKR1B15 (aldo-keto reductase family 1 member B15)
HGNC
EggNOG, HGNC, Inparanoid, OMA, Panther, PhylomeDB, Treefam
Homo sapiens (human):
AKR1B1 (aldo-keto reductase family 1 member B)
HGNC
OrthoDB
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Akr1b8 (aldo-keto reductase family 1, member B8)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Rattus norvegicus (Norway rat):
Akr1b10 (aldo-keto reductase family 1 member B10)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
AKR1B10 (aldo-keto reductase family 1 member B10)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
AKR1B15 (aldo-keto reductase family 1 member B15)
Alliance
DIOPT (HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
akr1b1.2 (aldo-keto reductase family 1, member B1 (aldose reductase), tandem duplicate 2)
Alliance
DIOPT (Hieranoid|OrthoFinder|PANTHER|PhylomeDB)
Drosophila melanogaster (fruit fly):
CG12766
Alliance
DIOPT (Ensembl Compara|Hieranoid|PhylomeDB)
Drosophila melanogaster (fruit fly):
CG6083
Alliance
DIOPT (Ensembl Compara|Hieranoid|OMA|OrthoFinder|PANTHER)
Drosophila melanogaster (fruit fly):
CG6084
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
GCY1
Alliance
DIOPT (Ensembl Compara|InParanoid|OMA|OrthoInspector|SonicParanoid)
Caenorhabditis elegans (roundworm):
Y39G8B.1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoInspector|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
Y39G8B.2
Alliance
DIOPT (Ensembl Compara|InParanoid|OrthoInspector|PANTHER)
Saccharomyces cerevisiae (baker's yeast):
YPR1
Alliance
DIOPT (Ensembl Compara|InParanoid|OMA|OrthoInspector|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG10638
Alliance
DIOPT (Ensembl Compara|Hieranoid|PhylomeDB)
Caenorhabditis elegans (roundworm):
C07D8.6
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Xenopus tropicalis (tropical clawed frog):
akr1b1
Alliance
DIOPT (OrthoFinder|PANTHER|PhylomeDB)
Related Pseudogenes:
Gm18799
Gm18832
Gm18835
Gm5649
Latest Assembly:
GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 6 34,331,081 - 34,345,396 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 6 34,331,054 - 34,345,398 (+) Ensembl GRCm39 Ensembl GRCm38 6 34,354,146 - 34,368,461 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 6 34,354,119 - 34,368,463 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 6 34,304,164 - 34,318,454 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 6 34,284,322 - 34,298,612 (+) NCBI MGSCv36 mm8 Celera 6 34,351,110 - 34,365,396 (+) NCBI Celera Cytogenetic Map 6 B1 NCBI cM Map 6 14.91 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AKR1B8 mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AKR1B8 mRNA CTD PMID:16960034 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of AKR1B8 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of AKR1B8 mRNA CTD PMID:21570461 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of AKR1B8 mRNA CTD PMID:30951980 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of AKR1B8 mRNA CTD PMID:19770486 and PMID:32417428 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of AKR1B8 mRNA CTD PMID:26377693 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AKR1B8 mRNA CTD PMID:30951980 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of AKR1B8 mRNA CTD PMID:30951980 buta-1,3-diene increases expression EXP 6480464 1 and 3-butadiene results in increased expression of AKR1B8 mRNA CTD PMID:29038090 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of AKR1B8 mRNA CTD PMID:23125180 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AKR1B8 mRNA CTD PMID:20938992 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of AKR1B8 mRNA CTD PMID:28472532 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AKR1B8 mRNA CTD PMID:30529165 diquat decreases expression EXP 6480464 Diquat results in decreased expression of AKR1B8 protein CTD PMID:36851058 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 folpet increases expression EXP 6480464 folpet results in increased expression of AKR1B8 mRNA CTD PMID:31558096 hypochlorous acid increases expression EXP 6480464 Hypochlorous Acid results in increased expression of AKR1B8 mRNA CTD PMID:19376150 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AKR1B8 mRNA CTD PMID:36331819 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AKR1B8 mRNA CTD PMID:20938992 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of AKR1B8 mRNA more ... CTD PMID:19555225 and PMID:34911549 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of AKR1B8 mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AKR1B8 mRNA CTD PMID:36331819 phosgene affects expression EXP 6480464 Phosgene affects the expression of AKR1B8 mRNA CTD PMID:16300373 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of AKR1B8 mRNA CTD PMID:18489776 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of AKR1B8 mRNA CTD PMID:17426115 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of AKR1B8 mRNA CTD PMID:23608068 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of AKR1B8 mRNA CTD PMID:22155349 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of AKR1B8 mRNA CTD PMID:15003993 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of AKR1B8 mRNA CTD PMID:27339419 and PMID:31919559 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of AKR1B8 mRNA CTD PMID:23557971 and PMID:27760801 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of AKR1B8 mRNA CTD PMID:17656681 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of AKR1B8 mRNA CTD PMID:20546886 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of AKR1B8 mRNA CTD PMID:18930951 zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of AKR1B8 protein CTD PMID:25058043 and PMID:36252740